John Christopher A
Melbourne Medical School, The University of Melbourne, Victoria 3010, Australia.
Melbourne School of Population and Global Health, The University of Melbourne, Victoria 3010, Australia.
Trop Med Infect Dis. 2019 Feb 5;4(1):28. doi: 10.3390/tropicalmed4010028.
This review article discusses how social approaches to tuberculosis elimination might contribute to realizing the targets stipulated in the World Health Organization's (WHO) End TB Strategy (2016⁻2035), with an emphasis on opportunities for progress in Asia and the Pacific. Many factors known to advance tuberculosis transmission and progression are pervasive in Asia and the Pacific, such as worsening drug resistance, unregulated private sector development, and high population density. This review article argues that social solutions must be revisited and improved upon if current worldwide tuberculosis rates are to be sustainably reduced in the long term. For the ambitious targets laid down in the WHO's End TB Strategy to be met, biomedical innovations such as point-of-care diagnostics and new treatments for multidrug-resistant tuberculosis (MDR-TB) must be implemented alongside economic, social, and environmental interventions. Implementing social, environmental, and economic interventions alongside biomedical innovations and universal healthcare coverage will, however, only be possible if the health and other government sectors, civil society, and at-risk populations unite to work collaboratively in coming years.
这篇综述文章讨论了结核病消除的社会方法如何有助于实现世界卫生组织（WHO）《终止结核病战略（2016 - 2035年）》规定的目标，重点关注亚太地区取得进展的机会。许多已知会促进结核病传播和进展的因素在亚太地区普遍存在，如耐药性恶化、私营部门发展不受监管以及人口密度高。这篇综述文章认为，如果要长期可持续地降低当前全球结核病发病率，就必须重新审视并改进社会解决方案。为了实现WHO《终止结核病战略》设定的宏伟目标，必须将即时诊断和耐多药结核病（MDR-TB）新疗法等生物医学创新与经济、社会和环境干预措施同时实施。然而，只有在未来几年卫生部门和其他政府部门、民间社会以及高危人群联合起来共同协作，才有可能将社会、环境和经济干预措施与生物医学创新及全民医保覆盖相结合。
